Author:
Xiang Ze,Li Jiarui,Zeng Huixuan,Xiang Xiaonan,Gao Fengqiang,Wang Kai,Wei Xuyong,Zheng Shusen,Xu Xiao
Reference165 articles.
1. Xiang Z, Wu J, Li J, Zheng S, Wei X, Xu X (2023). Gut Microbiota Modulation: A Viable Strategy to Address Medical Needs in Hepatocellular Carcinoma and Liver Transplantation. Engineering, S2095809923001443.
2. Houssin D, Franco D, Corlette MB, Bismuth H (1980). Criteria for hepatic transplantation in cirrhosis. Surg Gynecol Obstet, 151:30-32.
3. Xiao J, Wang F, Wong N-K, He J, Zhang R, Sun R, et al. (2019). Global liver disease burdens and research trends: Analysis from a Chinese perspective. J Hepatol, 71:212-221.
4. Xiang Z, Hua M, Hao Z, Biao H, Zhu C, Zhai G, et al. (2022). The Roles of Mesenchymal Stem Cells in Gastrointestinal Cancers. Front Immunol, 13:844001.
5. Chen J, Shen T, Li J, Ling S, Yang Z, Wang G, et al. (2022). Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition). Chinese Medical Journal, 135:2911-2913.